NATIONWIDE – The U.S. Department of Health and Human Services has ruled drug companies must disclose prices.
The ruling states pharmaceutical companies are required to list prices in direct-to-consumer advertising.
Sen. Angus King, I-Maine, released a statement saying the ruling will bring transparency to drug costs.
It went on to say, “For decades, pharmaceutical companies have been able to advertise their drugs to the public without disclosing their prices and all the while, those prices have continued to rise.”
According to the statement, the changes will help empower patients and lower prescription drug costs.